ARTN, artemin, 9048

N. diseases: 248; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0497169
Disease: hiv-infection/aids
hiv-infection/aids
0.100 Biomarker disease BEFREE We performed a systematic search for articles reporting on peer-reviewed, quantitative, English-language observational studies of reporting the association between self sero-status disclosure and good ART adherence in adults living with HIV/AIDS in Ethiopia during published from 2010 to 2015. 31208346 2019
CUI: C0497169
Disease: hiv-infection/aids
hiv-infection/aids
0.100 GeneticVariation disease BEFREE Factors Associated with Improved HIV/AIDS Treatment Outcomes: Comparing two Major ART Service Delivery Models in Vietnam. 31236748 2019
CUI: C0497169
Disease: hiv-infection/aids
hiv-infection/aids
0.100 GeneticVariation disease BEFREE From April 2017 to October 2018, 800 persons living with HIV/AIDS in a public HIV clinic in Miami completed an interviewer-administered behavioral and chart-review cross-sectional assessment to examine the prevalence and association of number of syndemics (unstable housing, low education, depression, anxiety, binge drinking, drug use, violence, HIV-related stigma) with poor ART adherence, unsuppressed HIV viral load (≥ 200 copies/mL), and biobehavioral transmission risk (condomless sex in the context of unsuppressed viral load). 31392443 2019
CUI: C0497169
Disease: hiv-infection/aids
hiv-infection/aids
0.100 GeneticVariation disease BEFREE Cross-sectional study conducted in the Chantal BIYA International Reference Centre for research on HIV/AIDS prevention and management (CIRCB), Yaoundé, Cameroon; data generated between October 2016 and August 2017 amongst adults, adolescents and children at 12, 24, 36 and ≥ 48 months on ART. 31744517 2019
CUI: C0497169
Disease: hiv-infection/aids
hiv-infection/aids
0.100 GeneticVariation disease BEFREE The main aim of the study was to determine the prevalence and associated risk factors of Cryptococcal antigenemia (CrAg) among HIV/AIDS Patients on second-line ART Therapy at Ambo General Hospital and Nekemte Referral Hospital, Western Oromia, Ethiopia. 31805085 2019
CUI: C0497169
Disease: hiv-infection/aids
hiv-infection/aids
0.100 Biomarker disease BEFREE Patient costs incurred by people living with HIV/AIDS prior to ART initiation in primary healthcare facilities in Gauteng, South Africa. 30742623 2019
CUI: C0497169
Disease: hiv-infection/aids
hiv-infection/aids
0.100 Biomarker disease BEFREE Acceptability and feasibility of short message service to improve ART medication adherence among people living with HIV/AIDS receiving antiretroviral treatment at Adama hospital medical college, Central Ethiopia. 31638936 2019
CUI: C0497169
Disease: hiv-infection/aids
hiv-infection/aids
0.100 Biomarker disease BEFREE Speech and language assessments were conducted as part of the Pediatric HIV/AIDS Cohort Study Surveillance Monitoring of ART Toxicities study at ages 3 (N = 208) and 5 (N = 429) years. 29278615 2018
CUI: C0497169
Disease: hiv-infection/aids
hiv-infection/aids
0.100 Biomarker disease BEFREE An institutional based retrospective cohort study were undertaken among 1439 adult people living with HIV/AIDS and attending ART clinic between September 1, 2007 and September 1, 2014 at Karamara Hospital was undertaken. 29914400 2018
CUI: C0497169
Disease: hiv-infection/aids
hiv-infection/aids
0.100 Biomarker disease BEFREE We conducted a cross-sectional examination of the physical and psychological factors related to ART adherence among a sample of 400 women living with HIV/AIDS in rural India. 27990577 2018
CUI: C0497169
Disease: hiv-infection/aids
hiv-infection/aids
0.100 GeneticVariation disease BEFREE Continued availability of ART (Anti-Retroviral Therapy) to HIV/AIDS patients, and test reagents for CD4 cell count and viral load determination are important measures to alleviate the suffering of these patients. 30558571 2018
CUI: C0497169
Disease: hiv-infection/aids
hiv-infection/aids
0.100 Biomarker disease BEFREE Since the discovery of the secondary preventive benefits of antiretroviral therapy, national and international governing bodies have called for countries to reach 90% diagnosis, ART engagement and viral suppression among people living with HIV/AIDS. 29802550 2018
CUI: C0497169
Disease: hiv-infection/aids
hiv-infection/aids
0.100 GeneticVariation disease BEFREE Cases of mother-to-child-transmission in the Surveillance Monitoring of ART Toxicities Study of Pediatric HIV/AIDS Cohort Study were identified from 2007 to 2015. 29742647 2018
CUI: C0497169
Disease: hiv-infection/aids
hiv-infection/aids
0.100 GeneticVariation disease BEFREE The impact of dark chocolate intake on arterial elasticity in individuals with HIV/AIDS undergoing ART: a randomized, double-blind, crossover trial. 28513635 2017
CUI: C0497169
Disease: hiv-infection/aids
hiv-infection/aids
0.100 Biomarker disease BEFREE In 2015, the WHO urged countries to provide ART to all people living with HIV, irrespective of their CD4 cell count, this new recommendation supports the Joint United Nations Programme on HIV/AIDS elimination targets. 28134713 2017
CUI: C0497169
Disease: hiv-infection/aids
hiv-infection/aids
0.100 Biomarker disease BEFREE 12,966 individuals received ART from HIV/AIDS sentinel hospitals and 1,919 from DDFs, with linkage to care rates of 80.7% and 79.9%, respectively (P > 0.05). 28195204 2017
CUI: C0497169
Disease: hiv-infection/aids
hiv-infection/aids
0.100 Biomarker disease BEFREE KIULARCO provides a framework for improving the quality of care of people living with HIV in sub-Saharan Africa, to generate relevant information to evaluate ART programmes and to build local capacity to deal with HIV/AIDS. 28695551 2017
CUI: C0497169
Disease: hiv-infection/aids
hiv-infection/aids
0.100 GeneticVariation disease BEFREE According to multivariate analysis, smoking (OR = 2.996, 0.992-9.053), lower CD 4+ T-cell count (OR = 3.288, 1.161-9.311), long duration of HIV-infection (OR = 5.946, 2.221-15.915) and non-use of ART (OR = 7.775, 2.618-23.094) were independent risk factors for TB in people living with HIV/AIDS. 28358846 2017
CUI: C0497169
Disease: hiv-infection/aids
hiv-infection/aids
0.100 GeneticVariation disease BEFREE Psychological model of ART adherence behaviors in persons living with HIV/AIDS in Mexico: a structural equation analysis. 28876412 2017
CUI: C0497169
Disease: hiv-infection/aids
hiv-infection/aids
0.100 GeneticVariation disease BEFREE New reports of HIV/AIDS cases to the national public health surveillance system (SIVIGILA) in Colombia have shown that there is a growing community at risk of contracting cryptococcosis throughout the country who do not have access to ART. 28591262 2017
CUI: C0497169
Disease: hiv-infection/aids
hiv-infection/aids
0.100 Biomarker disease BEFREE Currently, treatment of HIV/AIDS still depends on highly active antiretroviral therapy (HAART); however, there is increasing evidence showing the emergence of resistance to antiretroviral drugs in HIV-1 strains, making ART less effective over time. 25795166 2015